The Rising Prevalence Of Kidney Disease Drives Growth In The Chronic Kidney Disease Market: A Significant Driver Propelling The Chronic Kidney Disease Market In 2025

The Chronic Kidney Disease Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Chronic Kidney Disease Market Size and Projected Growth Rate?
The Chronic Kidney Disease Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Chronic Kidney Disease Market Size and Projected Growth Rate?

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969

What Are the Major Segments in the Chronic Kidney Disease Market?
The chronic kidney disease market covered in this report is segmented -

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy
2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments
3) By Route of Administration: Oral, Intravenous, Subcutaneous
4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:
1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests
2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)
3) By Imaging Test: Ultrasound, CT Scan, MRI, X-ray
4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

What Are The Driving Chronic Kidney Disease Market Evolution?
The growth of the chronic kidney disease market is expected to be fueled by the rising incidence of kidney disease. A collection of conditions that impact the kidneys' function and structure are referred to as kidney diseases. Blood pressure control in patients and reduction of protein loss to hinder kidney damage progression, manage symptoms and prevent later complications are the aims of kidney disease medication. To exemplify, the Centers for Disease Control and Prevention, a public health agency based in the US, stated in July 2022 that approximately 15%, or 37 million individuals in the US, had kidney disease. Consequently, the surge in kidney disease prevalence is a contributing factor to the expansion of the chronic kidney disease market.

Which Firms Dominate The Chronic Kidney Disease Market Segments?
Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

What Trends Are Expected to Dominate the Chronic Kidney Disease Market in the Next 5 Years?
The trend of product innovations is increasingly gaining traction in the chronic kidney disease market. To maintain competitiveness in this market, companies are focusing on producing innovative solutions. One such example is Bayer, a biotechnological and pharmaceutical firm based in Germany, who introduced Kerendia (finerenone), an innovative drug aimed at decelerating the progression of chronic kidney disease in individuals with diabetes, in August 2022. Kerendia, a first-in-class non-steroidal, selective mineralocorticoid receptor antagonist, sets itself apart from existing treatments as it inhibits mineralocorticoid receptor (MR) overactivity which contributes to the advancement of CKD and cardiovascular damage.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Which Is The Largest Region In The Chronic Kidney Disease Market?
North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Chronic Kidney Disease Market?
2. What is the CAGR expected in the Chronic Kidney Disease Market?
3. What Are the Key Innovations Transforming the Chronic Kidney Disease Industry?
4. Which Region Is Leading the Chronic Kidney Disease Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.